It suggests that T cells activated by ICIs may increase the expression of the receptor activator of nuclear factor-κB ligand (RANKL) and other cytokines, including tumor necrosis factor (TNF)-α and interleukin (IL)-18, IL-17, and IL-12, potentially leading to the development of osteoporosis. This evidence concerns the gene TNFSF11 and osteoporosis.